Anti-NDUS8/ NDUFS8/ CI-23k functional antibody

Anti-NDUS8/ NDUFS8/ CI-23k functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to NDUFS8/NDUFS8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1460-Ab-1/ GM-Tg-hg-SE1460-Ab-2Anti-Human NDUFS8 monoclonal antibodyHuman
GM-Tg-rg-SE1460-Ab-1/ GM-Tg-rg-SE1460-Ab-2Anti-Rat NDUFS8 monoclonal antibodyRat
GM-Tg-mg-SE1460-Ab-1/ GM-Tg-mg-SE1460-Ab-2Anti-Mouse NDUFS8 monoclonal antibodyMouse
GM-Tg-cynog-SE1460-Ab-1/ GM-Tg-cynog-SE1460-Ab-2Anti-Cynomolgus/ Rhesus macaque NDUFS8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1460-Ab-1/ GM-Tg-felg-SE1460-Ab-2Anti-Feline NDUFS8 monoclonal antibodyFeline
GM-Tg-cang-SE1460-Ab-1/ GM-Tg-cang-SE1460-Ab-2Anti-Canine NDUFS8 monoclonal antibodyCanine
GM-Tg-bovg-SE1460-Ab-1/ GM-Tg-bovg-SE1460-Ab-2Anti-Bovine NDUFS8 monoclonal antibodyBovine
GM-Tg-equg-SE1460-Ab-1/ GM-Tg-equg-SE1460-Ab-2Anti-Equine NDUFS8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1460-Ab-1/ GM-Tg-hg-SE1460-Ab-2; GM-Tg-rg-SE1460-Ab-1/ GM-Tg-rg-SE1460-Ab-2;
GM-Tg-mg-SE1460-Ab-1/ GM-Tg-mg-SE1460-Ab-2; GM-Tg-cynog-SE1460-Ab-1/ GM-Tg-cynog-SE1460-Ab-2;
GM-Tg-felg-SE1460-Ab-1/ GM-Tg-felg-SE1460-Ab-2; GM-Tg-cang-SE1460-Ab-1/ GM-Tg-cang-SE1460-Ab-2;
GM-Tg-bovg-SE1460-Ab-1/ GM-Tg-bovg-SE1460-Ab-2; GM-Tg-equg-SE1460-Ab-1/ GM-Tg-equg-SE1460-Ab-2
Products NameAnti-NDUFS8 monoclonal antibody
Formatmab
Target NameNDUFS8
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-NDUFS8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1460-Ag-1Recombinant multi-species NDUS8/ NDUFS8/ CI-23k protein


    Target information

    Target IDGM-SE1460
    Target NameNDUFS8
    Gene ID4728,225887,293652,710845,610413,101094451,287027,100053392
    Gene Symbol and SynonymsCI-23k,CI-23kD,CI23KD,MC1DN2,NDUFS8,TYKY
    Uniprot AccessionO00217,P42028
    Uniprot Entry NameNDUS8_HUMAN,NDUS8_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000110717
    Target ClassificationN/A

    The target: NDUFS8, gene name: NDUFS8, also named as CI-23k, CI23KD, TYKY. This gene encodes a subunit of mitochondrial NADH:ubiquinone oxidoreductase, or Complex I, a multimeric enzyme of the respiratory chain responsible for NADH oxidation, ubiquinone reduction, and the ejection of protons from mitochondria. The encoded protein is involved in the binding of two of the six to eight iron-sulfur clusters of Complex I and, as such, is required in the electron transfer process. Mutations in this gene have been associated with Leigh syndrome. [provided by RefSeq, Mar 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.